2025 Medicare Advantage reimbursement rates unchanged, causing 4-9% decline in US health insurers' shares.
US health insurers' shares declined between 4-9% following the CMS' announcement that Medicare Advantage reimbursement rates for providers were unchanged from the initial proposal for 2025, raising fears of a margin squeeze. The CMS expects Medicare Advantage plans to increase by 3.7% on average in 2025, consistent with the January proposal. This announcement led to share price declines for major health insurers, including UnitedHealth Group, Humana, and CVS Health.
April 01, 2024
17 Articles